arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

BALCHEM CORP

BCPC
$178.41 ▼ -4.20 (-2.30%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
69 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
79
Health
Good
Bullish
auto_awesome

Analytical Summary

BALCHEM CORP shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.7B
Dividend Yield —
Revenue Growth 8.6% ↘
Op. Margin 21.5% ↗
ROIC 3.7% ↗
FCF / Share $2.20 ↗
Trailing P/E 121.4x
Price / Book 4.3x
FCF Yield 1.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$290.66M
↑ +8.6% —
Net Income Profit after all expenses
$40.28M
↑ +8.7% —
Operating Margin Operating profit as % of sales
21.5%
↑ +3.0% 75th
FCF / Share Free cash flow per share
$2.20
↑ +50.3% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
78
Returns ↑
74
Financial Health ↓
88
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+10.3% YoY
+10.2% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters